US Stock MarketDetailed Quotes

XFOR X4 Pharmaceuticals

Watchlist

0.928
-0.031-3.26%

Close May 17 16:00 ET

0.944
+0.015+1.64%

Post 19:15 ET

155.91MMarket Cap-1385P/E (TTM)

X4 Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-26.72%-33.6M

-25.17%-96.51M

-45.33%-27.75M

-7.88%-20.83M

-15.97%-21.43M

-31.06%-26.51M

-8.74%-77.1M

-0.21%-19.09M

-35.85%-19.31M

3.77%-18.47M

Net income from continuing operations

-115.51%-51.77M

-7.78%-101.17M

34.27%-19.13M

89.32%-2.31M

-162.64%-55.71M

-9.36%-24.02M

-5.83%-93.87M

3.65%-29.1M

-6.99%-21.59M

-8.02%-21.21M

Operating gains losses

352.90%13.76M

-345.54%-7.07M

---6.33M

---25.16M

--29.86M

---5.44M

687.16%2.88M

----

Depreciation and amortization

-51.18%62K

-18.32%419K

-50.00%62K

-16.13%104K

-4.55%126K

-4.51%127K

2.81%513K

-6.06%124K

2.33%132K

Other non cash items

-6.44%523K

-6.44%2.28M

11.08%471K

-45.87%636K

55.98%613K

25.90%559K

-2.01%2.44M

-31.06%424K

44.00%1.18M

-15.30%393K

Change In working capital

239.29%2.09M

-94.00%344K

-197.86%-5.36M

2,823.08%3.54M

123.73%1.55M

305.33%616K

482.91%5.74M

512.90%5.48M

-103.71%-130K

135.45%691K

-Change in prepaid assets

-49.04%1.06M

-124.59%-1.37M

-138.15%-1.83M

96.98%-20K

-97.66%-1.61M

27.62%2.08M

65.24%-610K

55.89%-768K

-135.38%-663K

31.01%-812K

-Change in payables and accrued expense

204.11%1.27M

-60.68%2.84M

-150.52%-3.24M

397.17%3.87M

96.62%3.43M

28.23%-1.22M

612.82%7.23M

900.63%6.4M

-57.23%778K

374.06%1.74M

-Change in other current assets

----

--0

----

--0

----

-Change in other current liabilities

4.00%-240K

-27.89%-1.13M

-82.61%-294K

-25.71%-308K

-15.00%-276K

-5.93%-250K

-26.36%-882K

28.44%-161K

-26.94%-245K

-100.00%-240K

Cash from discontinued investing activities

Operating cash flow

-26.72%-33.6M

-25.17%-96.51M

-45.33%-27.75M

-7.88%-20.83M

-15.97%-21.43M

-31.06%-26.51M

-8.74%-77.1M

-0.21%-19.09M

-35.85%-19.31M

3.77%-18.47M

Investing cash flow

Cash flow from continuing investing activities

-59,033.33%-5.32M

-14,349.51%-14.88M

-14,114.71%-4.83M

-57,200.00%-5.16M

-12,752.63%-4.88M

59.09%-9K

83.25%-103K

-161.54%-34K

55.00%-9K

55.81%-38K

Net PPE purchase and sale

-555.56%-59K

41.75%-60K

-2.94%-35K

11.11%-8K

78.95%-8K

59.09%-9K

83.25%-103K

-161.54%-34K

55.00%-9K

55.81%-38K

Net investment purchase and sale

---5.26M

---14.82M

---4.8M

---5.15M

---4.88M

--0

----

Cash from discontinued investing activities

Investing cash flow

-59,033.33%-5.32M

-14,349.51%-14.88M

-14,114.71%-4.83M

-57,200.00%-5.16M

-12,752.63%-4.88M

59.09%-9K

83.25%-103K

-161.54%-34K

55.00%-9K

55.81%-38K

Financing cash flow

Cash flow from continuing financing activities

-24.49%88.52M

-99.84%97K

-59.20%21.21M

20,082.13%69.34M

-142.86%-2.12M

57.90%117.23M

146.82%60.64M

1,270.13%51.98M

62.45%-347K

Net issuance payments of debt

--0

2,670.57%20.44M

--0

4,938.04%22.12M

--0

-84.93%-1.68M

---795K

--0

--439K

---325K

Net common stock issuance

--0

-51.07%60M

--0

-116.24%-8.9M

315,272.73%69.34M

-107.54%-443K

65.75%122.63M

153.44%62.01M

1,332.96%54.77M

97.88%-22K

Proceeds from stock option exercised by employees

----

4,088.46%8.71M

-78.82%728K

----

-20.00%208K

3,237.86%3.44M

----

Net other financing activities

----

86.89%-631K

----

---4.81M

---4.8M

--0

Cash from discontinued financing activities

Financing cash flow

--0

-24.49%88.52M

-99.84%97K

-59.20%21.21M

20,082.13%69.34M

-142.86%-2.12M

57.90%117.23M

146.82%60.64M

1,270.13%51.98M

62.45%-347K

Net cash flow

Beginning cash position

-18.52%100.25M

48.03%123.03M

63.41%132.6M

182.35%137.46M

39.40%94.43M

48.03%123.03M

2.98%83.11M

4.41%81.15M

-49.55%48.68M

-41.93%67.74M

Current changes in cash

-35.87%-38.92M

-157.16%-22.88M

-178.24%-32.48M

-114.63%-4.78M

328.16%43.03M

-87.28%-28.65M

1,368.81%40.03M

654.31%41.52M

274.92%32.66M

6.67%-18.86M

Effect of exchange rate changes

-218.00%-59K

194.29%99K

-65.01%127K

63.45%-72K

97.03%-6K

172.46%50K

67.08%-105K

412.93%363K

-97.00%-197K

-605.00%-202K

End cash Position

-35.12%61.27M

-18.52%100.25M

63.41%132.6M

182.35%137.46M

39.40%94.43M

48.03%123.03M

4.41%81.15M

-49.55%48.68M

Free cash flow

-26.90%-33.66M

-25.09%-96.57M

-45.25%-27.78M

-7.87%-20.84M

-15.78%-21.43M

-30.96%-26.52M

-7.95%-77.21M

-0.32%-19.13M

-35.72%-19.32M

4.00%-18.51M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-26.72%-33.6M	-25.17%-96.51M	-45.33%-27.75M	-7.88%-20.83M	-15.97%-21.43M	-31.06%-26.51M	-8.74%-77.1M	-0.21%-19.09M	-35.85%-19.31M	3.77%-18.47M
Net income from continuing operations	-115.51%-51.77M	-7.78%-101.17M	34.27%-19.13M	89.32%-2.31M	-162.64%-55.71M	-9.36%-24.02M	-5.83%-93.87M	3.65%-29.1M	-6.99%-21.59M	-8.02%-21.21M
Operating gains losses	352.90%13.76M	-345.54%-7.07M	---6.33M	---25.16M	--29.86M	---5.44M	687.16%2.88M	----	----	----
Depreciation and amortization	-51.18%62K	-18.32%419K	-50.00%62K	-16.13%104K	-4.55%126K	-4.51%127K	2.81%513K	-6.06%124K	-6.06%124K	2.33%132K
Other non cash items	-6.44%523K	-6.44%2.28M	11.08%471K	-45.87%636K	55.98%613K	25.90%559K	-2.01%2.44M	-31.06%424K	44.00%1.18M	-15.30%393K
Change In working capital	239.29%2.09M	-94.00%344K	-197.86%-5.36M	2,823.08%3.54M	123.73%1.55M	305.33%616K	482.91%5.74M	512.90%5.48M	-103.71%-130K	135.45%691K
-Change in prepaid assets	-49.04%1.06M	-124.59%-1.37M	-138.15%-1.83M	96.98%-20K	-97.66%-1.61M	27.62%2.08M	65.24%-610K	55.89%-768K	-135.38%-663K	31.01%-812K
-Change in payables and accrued expense	204.11%1.27M	-60.68%2.84M	-150.52%-3.24M	397.17%3.87M	96.62%3.43M	28.23%-1.22M	612.82%7.23M	900.63%6.4M	-57.23%778K	374.06%1.74M
-Change in other current assets	----	--0	----	----	----	----	--0	----	----	----
-Change in other current liabilities	4.00%-240K	-27.89%-1.13M	-82.61%-294K	-25.71%-308K	-15.00%-276K	-5.93%-250K	-26.36%-882K	28.44%-161K	-26.94%-245K	-100.00%-240K
Cash from discontinued investing activities
Operating cash flow	-26.72%-33.6M	-25.17%-96.51M	-45.33%-27.75M	-7.88%-20.83M	-15.97%-21.43M	-31.06%-26.51M	-8.74%-77.1M	-0.21%-19.09M	-35.85%-19.31M	3.77%-18.47M
Investing cash flow
Cash flow from continuing investing activities	-59,033.33%-5.32M	-14,349.51%-14.88M	-14,114.71%-4.83M	-57,200.00%-5.16M	-12,752.63%-4.88M	59.09%-9K	83.25%-103K	-161.54%-34K	55.00%-9K	55.81%-38K
Net PPE purchase and sale	-555.56%-59K	41.75%-60K	-2.94%-35K	11.11%-8K	78.95%-8K	59.09%-9K	83.25%-103K	-161.54%-34K	55.00%-9K	55.81%-38K
Net investment purchase and sale	---5.26M	---14.82M	---4.8M	---5.15M	---4.88M	--0	--0	--0	--0	----
Cash from discontinued investing activities
Investing cash flow	-59,033.33%-5.32M	-14,349.51%-14.88M	-14,114.71%-4.83M	-57,200.00%-5.16M	-12,752.63%-4.88M	59.09%-9K	83.25%-103K	-161.54%-34K	55.00%-9K	55.81%-38K
Financing cash flow
Cash flow from continuing financing activities	0	-24.49%88.52M	-99.84%97K	-59.20%21.21M	20,082.13%69.34M	-142.86%-2.12M	57.90%117.23M	146.82%60.64M	1,270.13%51.98M	62.45%-347K
Net issuance payments of debt	--0	2,670.57%20.44M	--0	4,938.04%22.12M	--0	-84.93%-1.68M	---795K	--0	--439K	---325K
Net common stock issuance	--0	-51.07%60M	--0	-116.24%-8.9M	315,272.73%69.34M	-107.54%-443K	65.75%122.63M	153.44%62.01M	1,332.96%54.77M	97.88%-22K
Proceeds from stock option exercised by employees	----	4,088.46%8.71M	-78.82%728K	----	----	----	-20.00%208K	3,237.86%3.44M	----	----
Net other financing activities	----	86.89%-631K	----	----	----	----	---4.81M	---4.8M	--0	--0
Cash from discontinued financing activities
Financing cash flow	--0	-24.49%88.52M	-99.84%97K	-59.20%21.21M	20,082.13%69.34M	-142.86%-2.12M	57.90%117.23M	146.82%60.64M	1,270.13%51.98M	62.45%-347K
Net cash flow
Beginning cash position	-18.52%100.25M	48.03%123.03M	63.41%132.6M	182.35%137.46M	39.40%94.43M	48.03%123.03M	2.98%83.11M	4.41%81.15M	-49.55%48.68M	-41.93%67.74M
Current changes in cash	-35.87%-38.92M	-157.16%-22.88M	-178.24%-32.48M	-114.63%-4.78M	328.16%43.03M	-87.28%-28.65M	1,368.81%40.03M	654.31%41.52M	274.92%32.66M	6.67%-18.86M
Effect of exchange rate changes	-218.00%-59K	194.29%99K	-65.01%127K	63.45%-72K	97.03%-6K	172.46%50K	67.08%-105K	412.93%363K	-97.00%-197K	-605.00%-202K
End cash Position	-35.12%61.27M	-18.52%100.25M	-18.52%100.25M	63.41%132.6M	182.35%137.46M	39.40%94.43M	48.03%123.03M	48.03%123.03M	4.41%81.15M	-49.55%48.68M
Free cash flow	-26.90%-33.66M	-25.09%-96.57M	-45.25%-27.78M	-7.87%-20.84M	-15.78%-21.43M	-30.96%-26.52M	-7.95%-77.21M	-0.32%-19.13M	-35.72%-19.32M	4.00%-18.51M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall